CALL US: 206.533.3854
CALL US  206.533.3854
AEON Law logo full color transparent
By United States Copyright Office - copyright.gov, Public Domain, https://commons.wikimedia.org/w/index.php?curid=18497075

Copyright Office Seeks Public Comments on New “Small Claims” Program

Copyright Office
Seeks comments on small claims court;
Public can weigh in

As we wrote about in this recent blog, the COVID-19 stimulus relief and government-funding bill signed into law in December created a new “small claims court” for copyright matters.

The Copyright Alternative in Small-Claims Enforcement Act (“CASE Act”) revises the Copyright Act, 17 U.S.C. §§ 101 et seq. and creates a Copyright Claims Board (CCB) within the US Copyright Office.

The CCB will be able to decide on:

  • Copyright infringement claims
  • Declarations of non-infringement of copyright
  • Claims for failure to remove or disable access to allegedly infringing content after notice-and-takedown procedures under the Digital Millennium Copyright Act (DMCA) have been followed
  • Misrepresentation in connection with a DMCA claim
  • Counterclaims relating to the above
  • Defenses such as first sale and fair use

The CCB may not award more than $15,000 in statuary damages per copyrighted work, no more than $30,000 in total actual or statutory damages, and no more than $5,000 in attorney’s fees in cases of bad faith unless a party can present evidence of extraordinary circumstances.

The CCB is scheduled to become active by the end of December 2021.

Before that happens, the US Copyright Office is asking for the public to comment on the proposed process:

The Office must establish regulations to govern the CCB and its procedures, including rules addressing service of notice and other documents, waiver of personal service, notifications that parties are opting out of participating in the forum, discovery, a mechanism for certain claims to be resolved by a single CCB Officer, review of CCB determinations by the Register of Copyrights, publication of records, certifications, and fees. The statute also allows the Office to adopt several optional regulations, including regulations addressing claimants’ permissible number of cases, eligible classes of works, the conduct of proceedings, and default determinations.

The Copyright Office is asking for the public’s input on the following issues, among others:

Content of Initial Notices

To ensure that respondents are provided with proper notice of the claims asserted against them, along with information enabling a non-represented party to understand what the CCB is, and the process required to elect to participate or decline to do so, the statute details certain elements that must be included in the initial notice accompanying the claim

The Office is considering whether to include links in these formal notices that would allow defendants to better understand copyright law and their deadline for responding, obligations, and right to opt-out of the CCB process:

For example, should the notice provide information describing copyright or copyright infringement, as well as potential defenses that may be available to a respondent, such as fair use?

Opting Out

Generally, respondents who do not wish to have a claim heard by the CCB can opt out of proceedings on a case-by case basis. The statute includes two additional opt-out provisions: a blanket opt-out for libraries and archives who do not wish to participate in any CCB proceedings and a separate opt-out for parties who receive notice that they are class members in a pending class action involving the same transaction or occurrence as the CCB proceeding

The Office needs to decide whether opt-outs can be performed electronically, or only on paper.

Limits on Discovery

The statute allows for limited discovery in CCB proceedings. Discovery may include ‘‘the production of relevant information and documents, written interrogatories, and written requests for admission,’’ as established by Office regulations.

However, the Office notes that

discovery in the federal courts is the ‘‘primary reason for the length of federal court litigation’’ and is associated with ‘‘often substantial costs and potential for abuse by exploitative litigants.’’

Should there be a presumption against any discovery at all, as in some state small claims courts?

The Office seeks public input on whether there should be a limit on the number of interrogatories and requests for admission allowed without leave, what constitutes ‘‘good cause’’ to request additional information, and standards for determining when information is confidential.

More info on the CCB is here.


Just like the haiku above, we like to keep our posts short and sweet. Hopefully, you found this bite-sized information helpful. If you would like more information, please do not hesitate to contact us here.

Related Articles

Federal Circuit Finds No Motive to Combine in Laser Projector Patent Case

The Federal Circuit has reversed a finding by the Patent Trial and Appeal Board (PTAB or Board) that certain challenged claims of a patent for ...
Read More

Federal Circuit Affirms Blockchain Gem Patent Is Invalid

The Federal Circuit has affirmed a lower court’s decision finding the claims of a patent for preventing gemstone counterfeiting invalid. The case is Rady v. ...
Read More

Tennessee Passes Law Against AI Voice Copies

The state of Tennessee has passed a law against the use of artificial intelligence (AI) to copy a person’s voice. The law, signed on March ...
Read More

Let's work together.

Contact us to set up a meeting with an attorney or team member.

Stay Informed

Sign up to receive Patent Poetry—a monthly roundup of key IP issues in our signature haiku format. Four articles (only 68 syllables); zero hassle.

SECTORS

HIGH
TECHNOLOGY

Artificial Intelligence

Blockchain & Cryptocurrency

Computer Technology & Software

Consumer Electronics

Electrical Devices

MECHANICAL
& PRODUCTS​

Cleantech

Mechanical Devices

Consumer & Retail Products

Hardware & Tools

Toys & Games

LIFE SCIENCES
& CHEMISTRY​

Biotechnology

Chemical Compounds

Digital Health

Healthcare Products

Pharmaceuticals

BRANDING
& CREATIVE​

Books & Publications

Brand Creation

Luxury Products

Photography & Video

Product Design

SERVICES

PROTECT

DEAL

DEFEND